Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
How can we improve prognosis in diabetic patients with end-stage renal disease?
Autore:
Ritz, E; Koch, M; Fliser, D; Schwenger, V;
Indirizzi:
Univ Heidelberg, Dept Internal Med, D-69115 Heidelberg, Germany Univ Heidelberg Heidelberg Germany D-69115 , D-69115 Heidelberg, Germany Clin Nephrol & Rheumatol, Dusseldorf, Germany Clin Nephrol & Rheumatol Dusseldorf Germany umatol, Dusseldorf, Germany
Titolo Testata:
DIABETES CARE
, volume: 22, anno: 1999, supplemento:, 2
pagine: B80 - B83
SICI:
0149-5992(199903)22:<B80:HCWIPI>2.0.ZU;2-H
Fonte:
ISI
Lingua:
ENG
Soggetto:
LEFT-VENTRICULAR HYPERTROPHY; CORONARY-ARTERY DISEASE; DIALYSIS PATIENTS; FAILURE; NEPHROPATHY; SURVIVAL; DEATH; REGRESSION; THERAPY; LIPIDS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
27
Recensione:
Indirizzi per estratti:
Indirizzo: Ritz, E Univ Heidelberg, Dept Internal Med, Bergheimer Str 56A, D-69115 Heidelberg, Univ Heidelberg Bergheimer Str 56A Heidelberg Germany D-69115 rg,
Citazione:
E. Ritz et al., "How can we improve prognosis in diabetic patients with end-stage renal disease?", DIABET CARE, 22, 1999, pp. B80-B83

Abstract

Diabetes has become the single most important cause of end stage renal failure, bur survival of diabetic patients with renal replacement therapy continues to be poor. The major causes of death are cardiovascular complications. Most cardiovascular complications, particularly coronary atheroma, accumulate before patients enter renal replacement programs. This observation points to the need for im proved patient care in pre-end-stage renal failure. In the diabetic patient, dialysis should be started earlier than in the nondiabetic patient, and prophylactic vascular access should be established when the glomerular filtration rare is approximately 20 ml/min. Proposals toimprove prc,gnosis of the diabetic patient with renal failure include interdisciplinary care for the patients with renal disease, strict normotension, administration of ACE inhibitors, administration of lipid-lowering agents, near-normalization of anemia using recombinant human erythropoietin, and improvement of diabetic foot care in the patient on renal replacement therapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/09/20 alle ore 12:54:12